Comparative risk of pulmonary adverse events with transfusion of pathogen reduced and conventional platelet components.
Edward L SnyderAllison P WheelerMajed RefaaiClaudia S CohnJessica PoissonMagali J FontaineMary SehlAjay K NookaLynne UhlPhilip C SpinellaMaly FenelusDarla LilesThomas CoyleJoanne BeckerMichael JengEric Abraham GehrieBryan R SpencerPampee P YoungAndrew JohnsonJennifer J O'BrienGary J SchillerJohn D RobackElizabeth MalynnRonald JackupsScott T AvecillaJin-Sying LinKathy LiuStanley BentowHo-Lan PengJeanne VarroneRichard J BenjaminLaurence M CorashPublished in: Transfusion (2022)
PRPC demonstrated reduced TEAMV with no excess treatment-related pulmonary morbidity.
Keyphrases